BUSINESS
January 12, 1989 | From States News Service
Montgomery Medical Ventures II acquired the equivalent of a 23.2% stake in Alameda, Calif.-based Hana Biologics Inc., according to a filing with the Securities and Exchange Commission. Montgomery Medical, a venture capital fund created to make investments, bought 60,000 series A preferred shares that are convertible into about 1 million common shares. A warrant to buy 16.7 common shares was granted to Montgomery Medical for each preferred share it purchased.